SCHEMBL7215474

SCHEMBL7215474

O=C(OCc1ccccc1)C(CCN1C(=O)c2ccccc2C1=O)C(=O)OCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CASP3 P42574 2/20 0.50
MAPK1 P28482 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
ALDH1A1 P00352 2/20 0.48
LMNA P02545 1/20 0.48
POLB P06746 1/20 0.48
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
RAB9A P51151 1/20 0.47
CTRB1 P17538 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
HTT P42858 1/20 0.46
GAA P10253 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6578347 0.92 TDP1 (0.51) CASP3MAPK1SMN1; SMN2ALDH1A1LMNA
SCHEMBL20556174 0.82 HSD17B10 (0.49) SMN1; SMN2ALDH1A1TDP1GAA
SCHEMBL8574998 0.82 MAPK1 (0.56) CASP3MAPK1SMN1; SMN2ALDH1A1LMNA
SCHEMBL7080833 0.81 ALDH1A1 (0.58) CASP3SMN1; SMN2ALDH1A1
SCHEMBL408911 0.81 TDP1 (0.49) CASP3MAPK1SMN1; SMN2ALDH1A1LMNA
SCHEMBL20556320 0.80 MMP2 (0.51) SMN1; SMN2ALDH1A1TDP1GAA
SCHEMBL11209614 0.79 ALDH1A1 (0.54) MAPK1SMN1; SMN2ALDH1A1LMNAPOLB
SCHEMBL7374982 0.79 NPSR1 (0.62) CASP3SMN1; SMN2ALDH1A1LMNAPOLB
SCHEMBL27650814 0.79 ALDH1A1 (0.48) MAPK1SMN1; SMN2ALDH1A1LMNAPOLB
SCHEMBL20773790 0.77 MAPK1 (0.57) CASP3MAPK1SMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6566384-B1 For therapy of cancer, inflammation and inflammatory diseases, tissue degeneration, periodontal disease, ophthalmological disease, dermatological disorders, fever, cardiovascular effects, haemorrhage, coagulation and acute phase response DARWIN DISCOVERY LTD. (GB) 2003-05-20 US disclosed
CN-1227540-A Hydroxamic and carboxylic acid derivatives having MMP and TNF inhibitory activity DARWIN DISCOVERY CO LTD (GB) 1999-09-01 CN disclosed